0001518707-14-000003.txt : 20140206 0001518707-14-000003.hdr.sgml : 20140206 20140206133205 ACCESSION NUMBER: 0001518707-14-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140206 DATE AS OF CHANGE: 20140206 EFFECTIVENESS DATE: 20140206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Therapeutics, Inc. CENTRAL INDEX KEY: 0001518707 IRS NUMBER: 263843411 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-211425 FILM NUMBER: 14579178 BUSINESS ADDRESS: STREET 1: 611 OLIVE STREET STREET 2: SUITE 1260 CITY: ST. LOUIS STATE: MO ZIP: 63101 BUSINESS PHONE: 314-787-7475 MAIL ADDRESS: STREET 1: 611 OLIVE STREET STREET 2: SUITE 1260 CITY: ST. LOUIS STATE: MO ZIP: 63101 D 1 primary_doc.xml X0707 D LIVE 0001518707 Pulse Therapeutics, Inc. 611 OLIVE STREET SUITE 1260 ST. LOUIS MO MISSOURI 63101 314-787-7475 DELAWARE None None Corporation true Francis M. Creighton 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Executive Officer Director Thomas J. Hillman 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Director Bevil J. Hogg 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Director Stephen A. Wexler 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Director Peggy Stohr 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Executive Officer Sean Morris 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Executive Officer Eric A. Gulve 611 Olive Street Suite 1260 St. Louis MO MISSOURI 63101 Director Biotechnology Decline to Disclose 06b false 2013-12-23 false true false 25000 1500000 1025000 475000 false 3 0 0 0 false Pulse Therapeutics, Inc. Sean Morris Sean Morris Chief Executive Officer 2014-02-06